Diabetes type2
24
4
5
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.2%
1 terminated out of 24 trials
90.0%
+3.5% vs benchmark
8%
2 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (24)
Time-Restricted Eating for Type II Diabetes: TRE-T2D
Dietary Approaches to Stop Hypertension for Diabetes
Impact of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification
Intermittent Fasting to Improve Insulin Secretion
Diabetes Reversal and the Subgingival Microbiota
Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
Digital Individualized and Collaborative Treatment of T2D in General Practice Based on Decision Aid
Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation
Benefits of Nutritional Ingredients for Type 2 Diabetes
RESET System Pivotal Trial (Rev F)
A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150
Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT)
Organisational Models Supported by Technology for the Management of Diabetic Disease and Its Complications in a Diabetic Clinic Setting. A Randomised Controlled Trial Targeting Type 2 Diabetes Individuals With Non-ideal Glycemic Values
Training on Using ıInsulin in Patients With Type 2 Diabetes
The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly
The Canadian Diabetes Prevention Program
Epigenetic and Microbiota Modifications
Primary Care Based Integrated Community Care Team Intervention
Acceptance and Commitment Therapy Principles for Diabetes Prevention
Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells